Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study

Eva Steliarova-Foucher, Miranda M Fidler, Murielle Colombet, Brigitte Lacour, Peter Kaatsch, Marion Piñeros, Isabelle Soerjomataram, Freddie Bray, Jan Willem Coebergh, Rafael Peris-Bonet, Charles A Stiller, ACCIS contributors, Monika Hackl, Anna Zborovskaya, Nadya Dimitrova, Zdravka Valerianova, Ladislav Dušek, Margit Mägi, Alain Monnereau, Jacqueline Clavel, Michel Velten, Anne-Valérie Guizard, Véronique Bouvier, Xavier Troussard, Anne-Sophie Woronoff, Emilie Marrer, Brigitte Trétarre, Marc Colonna, Olivier Ganry, Pascale Grosclaude, Berndt Holleczek, Zsuzsanna Jakab, Laufey Tryggvadóttir, Lucia Mangone, Franco Merletti, Stefano Ferretti, Bianca Caruso, Maria Michiara, Rosario Tumino, Fabio Falcini, Roberto Zanetti, Giovanna Tagliabue, Otto Visser, Giske Ursin, Ryszard Mężyk, Kamila Kepska, José Laranja Pontes, Maja Primic Žakelj, Rafael Fernández-Delgado, Marisa L Vicente Raneda, Enrique Almar Marqués, José Ramón Quirós Garcia, Arantza Lopez de Munain, Rafael Marcos-Gragera, Maria-Jose Sanchez-Perez, Maria Ramos Monserrat, Eva Ardanaz, Jaume Galceran, Staffan Khan, Claudia E Kuehni, Christine Bouchardy, Fabio Levi, Isabelle Konzelmann, Sabine Rohrmann, Sally Vernon, David H Brewster, Ceri White, Anastasia Dolya, Eva Steliarova-Foucher, Miranda M Fidler, Murielle Colombet, Brigitte Lacour, Peter Kaatsch, Marion Piñeros, Isabelle Soerjomataram, Freddie Bray, Jan Willem Coebergh, Rafael Peris-Bonet, Charles A Stiller, ACCIS contributors, Monika Hackl, Anna Zborovskaya, Nadya Dimitrova, Zdravka Valerianova, Ladislav Dušek, Margit Mägi, Alain Monnereau, Jacqueline Clavel, Michel Velten, Anne-Valérie Guizard, Véronique Bouvier, Xavier Troussard, Anne-Sophie Woronoff, Emilie Marrer, Brigitte Trétarre, Marc Colonna, Olivier Ganry, Pascale Grosclaude, Berndt Holleczek, Zsuzsanna Jakab, Laufey Tryggvadóttir, Lucia Mangone, Franco Merletti, Stefano Ferretti, Bianca Caruso, Maria Michiara, Rosario Tumino, Fabio Falcini, Roberto Zanetti, Giovanna Tagliabue, Otto Visser, Giske Ursin, Ryszard Mężyk, Kamila Kepska, José Laranja Pontes, Maja Primic Žakelj, Rafael Fernández-Delgado, Marisa L Vicente Raneda, Enrique Almar Marqués, José Ramón Quirós Garcia, Arantza Lopez de Munain, Rafael Marcos-Gragera, Maria-Jose Sanchez-Perez, Maria Ramos Monserrat, Eva Ardanaz, Jaume Galceran, Staffan Khan, Claudia E Kuehni, Christine Bouchardy, Fabio Levi, Isabelle Konzelmann, Sabine Rohrmann, Sally Vernon, David H Brewster, Ceri White, Anastasia Dolya

Abstract

Background: A deceleration in the increase in cancer incidence in children and adolescents has been reported in several national and regional studies in Europe. Based on a large database representing 1·3 billion person-years over the period 1991-2010, we provide a consolidated report on cancer incidence trends at ages 0-19 years.

Methods: We invited all population-based cancer registries operating in European countries to participate in this population-based registry study. We requested a listing of individual records of cancer cases, including sex, age, date of birth, date of cancer diagnosis, tumour sequence number, primary site, morphology, behaviour, and the most valid basis of diagnosis. We also requested population counts in each calendar year by sex and age for the registration area, from official national sources, and specific information about the covered area and registration practices. An eligible registry could become a contributor if it provided quality data for all complete calendar years in the period 1991-2010. Incidence rates and the average annual percentage change with 95% CIs were reported for all cancers and major diagnostic groups, by region and overall, separately for children (age 0-14 years) and adolescents (age 15-19 years). We examined and quantified the stability of the trends with joinpoint analyses.

Findings: For the years 1991-2010, 53 registries in 19 countries contributed a total of 180 335 unique cases. We excluded 15 162 (8·4%) of 180 335 cases due to differing practices of registration, and considered the quality indicators for the 165 173 cases included to be satisfactory. The average annual age-standardised incidence was 137·5 (95% CI 136·7-138·3) per million person-years and incidence increased significantly by 0·54% (0·44-0·65) per year in children (age 0-14 years) with no change in trend. In adolescents, the combined European incidence was 176·2 (174·4-178·0) per million person-years based on all 35 138 eligible cases and increased significantly by 0·96% (0·73-1·19) per year, although recent changes in rates among adolescents suggest a deceleration in this increasing trend. We observed temporal variations in trends by age group, geographical region, and diagnostic group. The combined age-standardised incidence of leukaemia based on 48 458 cases in children was 46·9 (46·5-47·3) per million person-years and increased significantly by 0·66% (0·48-0·84) per year. The average overall incidence of leukaemia in adolescents was 23·6 (22·9-24·3) per million person-years, based on 4702 cases, and the average annual change was 0·93% (0·49-1·37). We also observed increasing incidence of lymphoma in adolescents (average annual change 1·04% [0·65-1·44], malignant CNS tumours in children (average annual change 0·49% [0·20-0·77]), and other tumours in both children (average annual change 0·56 [0·40-0·72]) and adolescents (average annual change 1·17 [0·82-1·53]).

Interpretation: Improvements in the diagnosis and registration of cancers over time could partly explain the observed increase in incidence, although some changes in underlying putative risk factors cannot be excluded. Cancer incidence trends in this young population require continued monitoring at an international level.

Funding: Federal Ministry of Health of the Federal German Government, the European Union's Seventh Framework Programme, and International Agency for Research on Cancer.

This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products, or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Figures

Figure 1
Figure 1
Incidence trends of cancer in children aged 0–14 years in Europe, 1991–2010 Jagged thin lines indicate annual age-standardised rates in countries and smooth red thick lines indicate modelled incidence trends in regions.
Figure 2
Figure 2
Overview of observed incidence trends of cancer in children aged 0–14 years for the entire study period and for any time segments identified in joinpoint analysis, by diagnostic group and region of Europe, 1991–2010 Red indicates an increasing trend, blue indicates a decreasing trend, and white indicates no significant trend. Absence of bars indicates no joinpoint was identified for a given category.
Figure 3
Figure 3
Overview of observed incidence trends of cancer in adolescents aged 15–19 years for the entire study period and for any significant time segments identified in joinpoint analysis, by diagnostic group and region of Europe, 1991–2010 Red indicates an increasing trend, blue indicates a decreasing trend, and white indicates no significant trend. Absence of bars indicates no joinpoint was identified for a given category.
Figure 4
Figure 4
Incidence trends of cancer in adolescents aged 15–19 years in Europe, 1991–2010 Jagged thin lines indicate annual age-specific rates in countries and smooth thick red lines indicate modelled incidence trends in regions.

References

    1. Steliarova-Foucher E, Colombet M, Ries LAG. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18:719–731.
    1. Steliarova-Foucher E, Stiller C, Kaatsch P. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet. 2004;364:2097–2105.
    1. AIRTUM Working Group. AIEOP Working Group Italian cancer figures, report 2012: cancer in children and adolescents. Epidemiol Prev. 2013;37(suppl 1):1–225.
    1. Marcos-Gragera R, Galceran J, Martos C. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007. Clin Transl Oncol. 2017;19:301–316.
    1. Nakata K, Ito Y, Magadi W. Childhood cancer incidence and survival in Japan and England: a population-based study (1993–2010) Cancer Sci. 2018;109:422–434.
    1. Svendsen AL, Feychting M, Klaeboe L, Langmark F, Schüz J. Time trends in the incidence of acute lymphoblastic leukemia among children 1976–2002: a population-based Nordic study. J Pediatr. 2007;151:548–550.
    1. Karim-Kos HE, Hackl M, Mann G. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994–2011. Cancer Epidemiol. 2016;42:72–81.
    1. Desandes E, Guissou S, Chastagner P, Lacour B. Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors. Neuro Oncol. 2014;16:975–983.
    1. Schmidt LS, Schmiegelow K, Lähteenmäki P. Incidence of childhood central nervous system tumors in the Nordic countries. Pediatr Blood Cancer. 2011;56:65–69.
    1. Peris-Bonet R, Salmerón D, Martínez-Beneito MA. Childhood cancer incidence and survival in Spain. Ann Oncol. 2010;21(suppl 3):iii103–iii110.
    1. Steliarova-Foucher E, Coebergh JW, Kaatsch P, Pritchard-Jones K, Stiller CA. Cancer in children and adolescents in Europe. Eur J Cancer. 2006;42:1913–2019.
    1. UN Statistics Division Methodology. Geographic regions.
    1. Fritz A, Percy C, Jack A. third edition. World Health Organization; Geneva: 2013. International classification of diseases for oncology.
    1. Percy C, Van Holten V, Muir CS. second edition. World Health Organization; Geneva: 1990. International classification of diseases for oncology.
    1. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005;103:1457–1467.
    1. Ferlay J, Burkhard C, Whelan S, Parkin DM. International Agency for Research on Cancer; Lyon: 2005. Check and conversion programs for cancer registries (IARC/IACR tools for cancer registries)
    1. Segi M, Fujisaku S, Kurihara M, Narai Y, Sasajima K. The age-adjusted death rates for malignant neoplasms in some selected sites in 23 countries in 1954–1955 and their geographical correlation. Tohoku J Exp Med. 1960;72:91–103.
    1. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829–836.
    1. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–351.
    1. UN Department of Economic and Social Affairs. Population Division World population prospects. 2017.
    1. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:1961–1971.
    1. Howlader N, Noone AM, Krapcho M, editors. SEER cancer statistics review, 1975–2014. National Cancer Institute; Bethesda: 2017.
    1. Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics. 2014;134:e945–e955.
    1. Kroll ME, Carpenter LM, Murphy MF, Stiller CA. Effects of changes in diagnosis and registration on time trends in recorded childhood cancer incidence in Great Britain. Br J Cancer. 2012;107:1159–1162.
    1. Shah A, Coleman MP. Increasing incidence of childhood leukaemia: a controversy re-examined. Br J Cancer. 2007;97:1009–1012.
    1. Kroll ME, Stiller CA, Richards S, Mitchell C, Carpenter LM. Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain. Br J Cancer. 2012;106:1556–1559.
    1. Marquant F, Goujon S, Faure L. Risk of childhood cancer and socio-economic disparities: results of the French Nationwide Study Geocap 2002–2010. Paediatr Perinat Epidemiol. 2016;30:612–622.
    1. Kehm RD, Spector LG, Poynter JN, Vock DM, Osypuk TL. Socioeconomic status and childhood cancer incidence: a population-based multilevel analysis. Am J Epidemiol. 2018;187:982–991.
    1. Chabay PA, Preciado MV. EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region. Int J Cancer. 2013;133:1286–1292.
    1. Stiller CA, Parkin DM. International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol. 1990;4:303–324.
    1. Carlberg M, Hedendahl L, Ahonen M, Koppel T, Hardell L. Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data. BMC Cancer. 2016;16:426.
    1. Pauniaho SL, Salonen J, Helminen M, Heikinheimo O, Vettenranta K, Heikinheimo M. Germ cell tumors in children and adolescents in Finland: trends over 1969–2008. Cancer Causes Control. 2014;25:1337–1341.
    1. Eggen CAM, Durgaram VVL, van Doorn R. Incidence and relative survival of melanoma in children and adolescents in the Netherlands, 1989–2013. J Eur Acad Dermatol Venereol. 2018;32:956–961.
    1. Steliarova-Foucher E, Stiller CA, Pukkala E, Lacour B, Plesko I, Parkin DM. Thyroid cancer incidence and survival among European children and adolescents (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2150–2169.

Source: PubMed

3
S'abonner